ストックスクリーナーアプリを入手
7.99
0.37%
-0.03
前日終値:
$8.02
開ける：
$8
24時間の取引高:
2.88M
Relative Volume:
0.65
時価総額：
$2.46B
収益：
$493.67M
当期純損益:
$-104.69M
株価収益率:
-23.50
EPS:
-0.34
ネットキャッシュフロー:
$-31.51M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+14.47%
6か月 パフォーマンス:
-10.12%
1年 パフォーマンス:
-29.17%
1日の値動き範囲:
$7.92
$8.11
1週間の範囲:
$7.785
$8.19
52週間の値動き範囲:
$5.51
$12.65
Amicus Therapeutics Inc Stock (FOLD) Company Profile
名前
Amicus Therapeutics Inc
セクター
電話
(609) 662-2000
住所
47 HULFISH STREET, PRINCETON, NJ
FOLD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FOLD
Amicus Therapeutics Inc
|
7.99 | 2.45B | 493.67M | -104.69M | -31.51M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-09-06 | 開始されました | Jefferies | Buy |
| 2024-05-30 | 開始されました | Wells Fargo | Overweight |
| 2024-05-14 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-12-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 再開されました | Goldman | Neutral |
| 2022-01-14 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-15 | アップグレード | Stifel | Hold → Buy |
| 2021-09-30 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-07-19 | 再開されました | BTIG Research | Buy |
| 2021-05-27 | 開始されました | Needham | Hold |
| 2021-05-21 | 開始されました | UBS | Buy |
| 2021-04-14 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2021-02-12 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-28 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-12-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-11-11 | 開始されました | Berenberg | Hold |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2020-02-04 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-11-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-06-17 | 開始されました | H.C. Wainwright | Buy |
| 2019-06-05 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2019-04-05 | 開始されました | Janney | Buy |
| 2019-01-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-10-29 | 開始されました | Citigroup | Neutral |
| 2018-08-17 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2017-10-06 | 再開されました | Goldman | Neutral |
| 2017-09-13 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-08-10 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-01-24 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2016-05-18 | 開始されました | BofA/Merrill | Buy |
| 2016-04-14 | 開始されました | Robert W. Baird | Neutral |
| 2016-04-12 | 繰り返されました | Chardan Capital Markets | Buy |
| 2015-09-16 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2015-06-16 | 繰り返されました | Chardan Capital Markets | Buy |
すべてを表示
Amicus Therapeutics Inc (FOLD) 最新ニュース
Comerica Bank Decreases Stock Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Parkman Healthcare Partners LLC Reduces Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Cubist Systematic Strategies LLC Invests $4.51 Million in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Trexquant Investment LP Sells 715,377 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
166,491 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by Banque Transatlantique SA - MarketBeat
Amicus Therapeutics Presents Long-Term Efficacy Data for Cipaglucosidase Alfa and Miglustat in Late-Onset Pompe Disease at ICIEM 2025 - Quiver Quantitative
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM - GlobeNewswire
Breakthrough 4-Year Results: Amicus Pompe Disease Treatment Maintains Muscle Function in Long-term Study - Stock Titan
Vestal Point Capital LP Grows Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Dark Forest Capital Management LP Raises Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Palo Alto Investors LP Sells 317,477 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
683 Capital Management LLC Acquires New Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics, Inc. $FOLD is Redmile Group LLC's 3rd Largest Position - MarketBeat
PDT Partners LLC Buys 388,817 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Rafferty Asset Management LLC Trims Stock Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Can Amicus Therapeutics Inc. outperform under higher oil pricesPrice Action & Expert-Curated Trade Recommendations - خودرو بانک
Ranking Amicus Therapeutics Inc. among high performing stocks via toolsWeekly Investment Recap & Advanced Technical Signal Analysis - Newser
What analysts say about Amicus Therapeutics Inc. stockWeekly Profit Recap & Verified Chart Pattern Trade Signals - خودرو بانک
Is Amicus Therapeutics Inc. a candidate for recovery playPortfolio Return Summary & AI Driven Stock Reports - Newser
Can a trend reversal in Amicus Therapeutics Inc. lead to recoveryJuly 2025 Update & Safe Capital Allocation Plans - Newser
Amicus Therapeutics Inc. stock momentum explained2025 Market Sentiment & Growth Focused Investment Plans - Newser
How to read the order book for Amicus Therapeutics Inc.2025 Stock Rankings & Daily Market Momentum Tracking - Newser
Is this a good reentry point in Amicus Therapeutics Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - Newser
Using economic indicators to assess Amicus Therapeutics Inc. potentialJuly 2025 Recap & Pattern Based Trade Signal System - Newser
Evaluating Amicus Therapeutics Inc. with trendline analysisMarket Performance Recap & Reliable Price Breakout Alerts - Newser
Is Amicus Therapeutics Inc. reversing from oversold territory2025 Macro Impact & Verified Momentum Watchlists - Newser
Quantitative breakdown of Amicus Therapeutics Inc. recent moveMarket Rally & Scalable Portfolio Growth Methods - Newser
Kodai Capital Management LP Purchases New Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Using AI based signals to follow Amicus Therapeutics Inc.Portfolio Performance Report & AI Forecasted Entry/Exit Points - Newser
Wall Street Zen Downgrades Amicus Therapeutics (NASDAQ:FOLD) to Hold - MarketBeat
Should you hold or exit Amicus Therapeutics Inc. now2025 Volatility Report & Short-Term Trading Alerts - Newser
Russell Investments Group Ltd. Increases Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Real time social sentiment graph for Amicus Therapeutics Inc.2025 Macro Impact & Safe Entry Momentum Stock Tips - Newser
Reversal indicators forming on Amicus Therapeutics Inc. stockJuly 2025 Drop Watch & Reliable Price Breakout Alerts - Newser
Using Python tools to backtest Amicus Therapeutics Inc. strategiesCEO Change & Reliable Price Action Trade Plans - Newser
Earnings visualization tools for Amicus Therapeutics Inc.2025 AllTime Highs & Verified Short-Term Plans - Newser
How to build a custom watchlist for Amicus Therapeutics Inc.2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Applying Wyckoff theory to Amicus Therapeutics Inc. stockJuly 2025 Levels & Safe Capital Investment Plans - Newser
Is Amicus Therapeutics Inc. stock a buy or sell getLinesFromResByArray error: size == 0 - 머스트 뉴스
Has Amicus Therapeutics Inc. found a price floorMarket Risk Analysis & Low Risk High Reward Trade Ideas - Newser
Amicus Therapeutics Inc (FOLD) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):